diaminopimelic acid has been researched along with fr 41565 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolodziejczyk, AM; Kolodziejczyk, AS; Stoev, S | 1 |
| Ahmed, K; Turk, JL; van der Meide, PH | 1 |
| Ivanitskaia, LP; Khurnova, LM | 1 |
| Ahmed, K; Turk, JL | 1 |
| Kikuchi, H; Mine, Y; Tawara, S; Watanabe, Y | 1 |
| Altom, MG; Schultz, RM | 1 |
| Leyhausen, G; Maidhof, A; Müller, WE; Tanaka, W; Umezawa, H; Weissmann, N | 1 |
| Aoki, H; Gotoh, T; Imanaka, H; Inamura, N; Kawamura, I; Kino, T; Nakahara, K; Sone, S | 1 |
| Fukada, S; Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Wakai, Y; Yokota, Y | 1 |
| Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Wakai, Y; Watanabe, Y; Yokota, Y | 1 |
| Mutsuura, S; Ogawara, M; Sone, S; Tsubura, E; Utsugi, T | 1 |
| Goto, S; Kuwahara, S; Mine, Y; Nishida, M; Tawara, S; Watanabe, Y; Yokota, Y | 1 |
| Del Valle, JR; Goodman, M | 1 |
| Aiba, S; Ohteki, T; Shibata, K; Tada, H; Takada, H | 1 |
| Asada, Y; Endo, Y; Funayama, H; Huang, L; Takada, H | 1 |
| Endo, Y; Sato, T; Shikama, Y; Shimauchi, H; Takada, H | 1 |
1 review(s) available for diaminopimelic acid and fr 41565
| Article | Year |
|---|---|
[Low-molecular weight immunomodulators of microbial origin].
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Diaminopimelic Acid; Glycine; Guinea Pigs; Immunologic Deficiency Syndromes; Leucine; Mice; Molecular Weight; Neoplasms, Experimental; Oligopeptides | 1989 |
15 other study(ies) available for diaminopimelic acid and fr 41565
| Article | Year |
|---|---|
New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.
Topics: Adjuvants, Immunologic; Chromatography, High Pressure Liquid; Diaminopimelic Acid; Hydrolysis; Oligopeptides | 1992 |
Effect of anticancer drugs on the release of interferon gamma in vitro.
Topics: Animals; Antineoplastic Agents; Bleomycin; Concanavalin A; Cyclosporins; Diaminopimelic Acid; Doxorubicin; In Vitro Techniques; Interferon-gamma; Male; Oligopeptides; Rats; Rats, Inbred Lew; Vincristine | 1989 |
Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzodiazepinones; Diaminopimelic Acid; Dose-Response Relationship, Immunologic; Interleukin-1; Interleukin-2; Male; Oligopeptides; Rats; Rats, Inbred Lew; Spleen | 1989 |
Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Diaminopimelic Acid; Lysosomes; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Muramidase; Oligopeptides; Phagocytosis; Superoxides; T-Lymphocytes | 1985 |
Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
Topics: 2-Chloroadenosine; Adenosine; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Diaminopimelic Acid; In Vitro Techniques; Lung Neoplasms; Lymphokines; Macrophage Activation; Macrophage-Activating Factors; Male; Mice; Mice, Inbred BALB C; Oligopeptides | 1986 |
Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Aminopeptidases; Amphotericin B; Animals; Anti-Bacterial Agents; Diaminopimelic Acid; Dipeptides; Glutamyl Aminopeptidase; Leucine; Leucyl Aminopeptidase; Lymphocyte Activation; Lymphocytes; Male; Mice; Mitogens; Oligopeptides; Peptides; Spleen | 1985 |
Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Cell Line; Cytotoxicity, Immunologic; Diaminopimelic Acid; Female; Lung Neoplasms; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Oligopeptides | 1985 |
Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Bacterial Infections; Candidiasis; Diaminopimelic Acid; Escherichia coli; Immunity, Innate; Listeria monocytogenes; Male; Mice; Mice, Inbred ICR; Oligopeptides; Structure-Activity Relationship | 1983 |
Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Antibiotics, Antineoplastic; Bacterial Infections; Carrageenan; Cyclophosphamide; Diaminopimelic Acid; Drug Synergism; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; Male; Mice; Mice, Inbred ICR; Mitomycin; Mitomycins; Oligopeptides; Phagocytosis; Sarcoma 180 | 1983 |
Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Cytotoxicity, Immunologic; Diaminopimelic Acid; Liposomes; Macrophage Activation; Macrophages; Mammary Neoplasms, Experimental; Oligopeptides; Rats; Rats, Inbred F344; Structure-Activity Relationship | 1984 |
Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Bacterial Infections; Candidiasis; Chemotaxis; Cyclophosphamide; Diaminopimelic Acid; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; Leukocyte Count; Macrophages; Male; Mice; Mice, Inbred ICR; Neutrophils; Oligopeptides; Phagocytosis | 1983 |
An efficient RCM-based synthesis of orthogonally protected meso-DAP and FK565.
Topics: Cyclization; Diaminopimelic Acid; Molecular Conformation; Oligopeptides | 2004 |
Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adaptor Proteins, Signal Transducing; Adjuvants, Immunologic; Cytokines; Dendritic Cells; Diaminopimelic Acid; Drug Synergism; Humans; Interleukin-12; Intracellular Signaling Peptides and Proteins; Lipid A; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligodeoxyribonucleotides; Oligopeptides; Poly I-C; Polylysine; RNA, Messenger; Th1 Cells; Toll-Like Receptors | 2005 |
Enhanced induction of a histamine-forming enzyme, histidine decarboxylase, in mice primed with NOD1 or NOD2 ligand in response to various Toll-like receptor agonists.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Diaminopimelic Acid; Histamine; Histidine Decarboxylase; Indicators and Reagents; Lipid A; Lung; Male; Mice; Mice, Inbred BALB C; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligopeptides; Toll-Like Receptors | 2010 |
Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
Topics: Acetic Acid; Acetylmuramyl-Alanyl-Isoglutamine; Analgesics; Animals; Diaminopimelic Acid; Drug Antagonism; Female; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Naloxone; Narcotic Antagonists; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligopeptides; Pain; Pain Measurement; Time Factors; Tumor Necrosis Factor-alpha | 2011 |